Who owns IRONWOOD PHARMACEUTICALS INC?
- CUSIP Number: 46333xah1
Tip: Access positions for across all investors
Analyze quarterly positions in Ironwood Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Ironwood Pharmaceuticals stock
Who bought or sold IRONWOOD PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Camden Asset Management | 50M | $49B | 0% | Sep 2023 |
|
Wolverine Asset Management | 34M | $37M | -13% | Dec 2023 |
|
Wellesley Investment Advisors | 27M | $29B | 100% | Dec 2023 |
|
Balyasny Asset Management | 25M | $27M | 100% | Dec 2023 |
|
Braidwell | 16M | $17M | 0% | Dec 2023 |
|
Capstone Investment Advisors | 15M | $17M | 0% | Dec 2023 |
|
Readystate Asset Management | 12M | $13M | 0% | Dec 2023 |
|
Calamos Advisors | 9.5M | $10M | 0% | Dec 2023 |
|
CSS | 6.5M | $7.1M | 18% | Dec 2023 |
|
Jane Street | 3.8M | $4.0M | 0% | Dec 2023 |
|
Jpmorgan Chase & Co | 2.4M | $2.6M | 195% | Dec 2023 |
|
Shenkman Capital Management | 2.1M | $2.3B | -36% | Dec 2023 |
|
FMR | 2.0M | $1.9M | 100% | Sep 2023 |
|
Citigroup | 249k | $270k | 0% | Dec 2023 |
|
Leucadia National Corporation | 203k | $198k | 100% | Sep 2023 |
|
D.A. Davidson & Co. | 135k | $147k | 100% | Dec 2023 |
|
HPM Partners | 36k | $39k | 100% | Dec 2023 |
|
Multi-Financial Securities | 32k | $31k | 0% | Sep 2023 |
|
Foresight Capital Management Advisors | 26k | $28k | 100% | Dec 2023 |
|
Morgan Stanley | 9.0k | $8.7k | 0% | Sep 2023 |
|
Boussard & Gavaudan Investment Management | 6.6k | $6.5M | 0% | Sep 2023 |
|
Northwestern Mutual Wealth Management Company | 6.0k | $5.8k | 0% | Sep 2023 |
|
Wells Fargo & Company | 1.0k | $1.1k | 0% | Dec 2023 |
|
Who sold out of Ironwood Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Citadel Advisors | Sep 2023 | 27M | $27M |
Deutsche Bank Aktiengesellschaft | Sep 2023 | 100k | $97k |